T2D accounts for over 90% of all‐case diabetes and the current therapeutic approaches for clinical T2D intervention mainly include lifestyle changes, prescription of anti‐diabetics and insulin replacement therapy.1, 2, 3. This evidence concerns the gene INS and type 2 diabetes mellitus.